The future of cancer treatment may lie in genetically engineered bacteria

May 23, 2021
Researchers from Yale University and Yale School of Medicine have genetically engineered E. coli bacteria to resist viral infection and undesirable gene transfer, opening up new pathways for medical research as well as better production of medicines, chemicals and numerous other products derived from biological sources.
Read article